Shareholding disclosure

Credit Suisse Funds AG

Declared position

9.99%

Threshold

Crossed upwards

Timeline

Published

09.02.2021

Transaction

02.02.2021

Voting rights breakdown

Voting rights acquired9.99%

Voting rights sold0%

Below threshold0%

Notice details

CategoryCollective investment vehicle

ExchangeXSWX

Notification ID

TCL2500015

Beneficial owner

Credit Suisse Funds AG

Declared address

Credit Suisse Funds AG, Zurich

Open shareholder profile Open company profile

Back to the feed

Shareholding disclosure

Credit Suisse Funds AG

Kuros Biosciences AG09.02.2021TCL2500015

Disclosure summary

Credit Suisse Funds AG disclosed a holding in Kuros Biosciences AG on the acquisition side, published by SIX Exchange Regulation on 09.02.2021, at 9.99% of voting rights. Notice category: Collective investment vehicle.

Disclosed position

9.99%

Voting rights acquired

Voting rights acquired9.99%

Voting rights sold0%

Below threshold0%

Never miss a market signal again

Create a free account

Need more? Discover the Pro plan

Pro alertsEmail and Telegram after publication

Unlimited company trackingUnlimited watchlist with the Pro plan

Monday recapYour stocks' essentials at the open

Disclosure detail

Credit Suisse Funds AG disclosed a holding in Kuros Biosciences AG, published on 09.02.2021.

Publication date09.02.2021

Transaction date02.02.2021

Issuing companyKuros Biosciences AG

Beneficial ownerCredit Suisse Funds AG

Declared addressCredit Suisse Funds AG, Zurich

CategoryCollective investment vehicle

Voting rights acquired9.99%

Voting rights sold0%

Below threshold0%

ExchangeXSWX

Notification IDTCL2500015

Commercial register

CHE-102.923.465

Struck off the register · 03.05.2024

Zefix record

Source: SIX Exchange Regulation · Publication date: 09.02.2021

These figures aggregate public disclosures. They are not investment advice.

insider24.ch

Never miss a market signal again

Create a free account

Need more? Discover the Pro plan

Pro alertsEmail and Telegram after publication

Unlimited company trackingUnlimited watchlist with the Pro plan

Monday recapYour stocks' essentials at the open